A study by Kazi et al. [133] applied phosphoproteomics analysis to KRAS mutant dependent and non-dependent pancreatic cancer cell lines to reveal a key role of CDK kinases in KRAS dependency. This evidence concerns the gene KRAS and familial pancreatic carcinoma.